Pasar al contenido principal

IMPACTO DE LA SEÑALIZACION ASTROCITARIA EN LA CONDUCTA SOCIAL

PID2022-142617NB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 12
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Astrocytopathy is associated with CA1 synaptic dysfunction in a mouse model of Down syndrome

  • Fernández-Blanco, Álvaro
  • González-Arias, Candela
  • Sierra, Cesar
  • Zamora Moratalla, Alfonsa
  • Perea, Gertrudis
  • Dierssen, Mara
Brain pathophysiology in Down syndrome (DS), the most common genetic cause of intellectual disability, has traditionally been considered a consequence of neuronal dysfunction. However, although it is well documented that astrocytes play a critical role in brain homeostasis, synaptic regulation, and neuronal support, and their malfunction has been associated with the onset and progression of different neurological disorders, only a few studies have addressed whether astrocyte dysfunction can contribute to the DS pathophysiology. Astrocytes are increased in number and size, and show increased levels of expression of astroglial markers like S100ß and GFAP. In this study, we detected a region-specific increase in astrocyte population in CA1 and, to a lesser extent, in the dentate gyrus. Single-nucleus transcriptomic profiling identified markers associated with reactive astroglia, synaptic transmission, and neuroinflammation in trisomic astrocytes. Functional analysis revealed abnormal Ca2+ oscillations in trisomic astrocytes and impaired astrocyte-to-neuron communication in CA1, the most affected subregion, leading to astrocyte-mediated excitatory synaptic depression. Our findings demonstrate that astrocytes play an active and critical role in the pathophysiology of DS, not only as reactive responders to neuronal injury but as key contributors to the disease process itself. This astrocytic dysfunction presents a region-specific distribution within the hippocampus, suggesting localized vulnerability and complex glial involvement in DS-related neuropathology., The lab of MD is supported by the Secretaria d¿Universitats i Recerca del Departament d'Economia I Coneixement de la Generalitat de Catalunya (Grups consolidats 2017 SGR 926). We also acknowledge the support of the Agencia Estatal de Investigación (PID2022-141900OB-I00 INTO-DS funded by MICIU/AEI/10.13039/501100011033/FEDER, UE). This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 848077). The publication is part of the grant PRE2018-084504, funded by MCIN/AEI/10.13039/501100011033 and by the FSE+ (AFB). Additionally, we have been supported by Fundació La Marató TV3 (201620-31 and 225619), and by PID2022-142617NB-I00 and PID2019-106579RB-I00 funded by MCIN/AEI/10.13039/501100011033 to G.P.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Restoration of CB1 receptor function in hippocampal GABAergic neurons rescues memory deficits in Huntington's disease models

  • Franco, Nadia Di
  • Bengoetxea de Tena, Iker
  • Sanchez-Ruiz, Andrea
  • Pereda-Velarde, Alba
  • Enfedaque, Ferran
  • González-Arias, Candela
  • Miquel-Rio, Lluis
  • Bortolozzi, Analía
  • Rodríguez-Puertas, Rafael
  • Costas-Insua, Carlos
  • Molina-Porcel, Laura
  • Vázquez-Oliver, Anna
  • Ozaita Mintegui, Andrés, 1969-
  • Guzmán, Manuel
  • Perea, Gertrudis
  • Ginés, Silvia
Background: Dysregulation of the endocannabinoid system (eCBS) and the loss of CB1 receptors (CB1R) in the basal ganglia are well-established hallmarks of Huntington's disease (HD). As a result, significant research efforts have focused on targeting the eCBS to alleviate motor disturbances associated with the disease. Beyond its role in motor control, the eCBS is a complex signaling network critically involved in regulating learning and memory. Despite this, the potential involvement of eCBS dysfunction in the cognitive decline characteristic of HD, often manifested well before motor dysfunction, has remained largely unexplored. Methods: CB1R expression in the hippocampus was evaluated in both human HD samples and HD mouse models (R6/1 and Hdh models, including both sexes) using Western blotting, immunohistochemistry, and radioligand binding assays. To restore CB1R function, CB1R agonist WIN-55212-2 was systemically administered, or viral vectors encoding CB1R were locally infused into the hippocampus of HD mice. A multidisciplinary approach combining behavioral, biochemical, electrophysiological, and morphological analyses, was employed to investigate the molecular mechanisms underlying the effects of CB1R activation in the context of HD-related cognitive dysfunction. Results: In both human HD samples and HD mouse models, CB1R protein levels were reduced in the hippocampus, accompanied by structural synaptic alterations and impairment in spatial, recognition and working memory. Moreover, hippocampal depolarization-induced suppression of inhibition was significantly disrupted in R6/1 mice. Administration of WIN-55212-2 successfully restored these synaptic and cognitive deficits. Immunohistochemical analysis revealed that the CB1R decrease was specifically localized to GABAergic interneurons within the hippocampus. Notably, targeted restoration of CB1R expression in these interneurons via viral vector delivery was sufficient to rescue hippocampal-dependent memory deficits in HD mice. Conclusion: This study suggests that impaired CB1R function in hippocampal GABAergic interneurons contributes to memory dysfunction in HD., This work was supported by the Spanish Ministerio de Ciencia e Innovación (PID2021-123732OB-I00 to SG, PID2021-125118OB-I00 to MG, PID2019-106579RB-I00, and PID2022-142617NB-I00 to GP, and PID2022-141700OB-I00 to AB funded by MCIN/AEI/ https://doi.org/10.13039/501100011033). Fundació la Marató de TV3 (202013-30-31-32 to SG, MG and GP), AGAUR Generalitat de Catalunya (2021-SGR-01358 to AB and 2021-SGR 01086 to SG) and grants to R. R.-P. rom the Basque Government IT1454-22 to the "Neurochemistry and Neurodegeneration" consolidated research group; Instituto de Salud Carlos III through the project PI20/00153 (co-funded by European Regional Development Fund "A way to make Europe") and by BIOEF through the project BIO22/ALZ/010 funded by Eitb Maratoia. A P-V is the recipient of a PRE2022-101764 fellowship (PID2021-123732OB-I00). I.B.d.T. is the recipient of an Investigo fellowship funded by the European Union-Next Generation EU.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The CB 1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls

  • Costas-Insua, Carlos
  • Hermoso-López, Alba
  • Moreno, Estefanía
  • Montero-Fernández, Carlos
  • Álvaro-Blázquez, Alicia
  • Maroto, Irene B.
  • Sánchez-Ruiz, Andrea
  • Diez-Alarcia, Rebeca
  • Blázquez, Cristina
  • Morales, Paula
  • Canela, Enric I.
  • Casadó, Vicent
  • Urigüen, Leyre
  • Perea, Gertrudis
  • Bellocchio, Luigi
  • Rodríguez-Crespo, Ignacio
  • Guzmán, Manuel
Cereblon/CRBN is a substrate-recognition component of the Cullin4A-DDB1-Roc1 E3 ubiquitin ligase complex. Destabilizing mutations in the human CRBN gene cause a form of autosomal recessive non-syndromic intellectual disability (ARNSID) that is modelled by knocking-out the mouse Crbn gene. A reduction in excitatory neurotransmission has been proposed as an underlying mechanism of the disease. However, the precise factors eliciting this impairment remain mostly unknown. Here we report that CRBN molecules selectively located on glutamatergic neurons are necessary for proper memory function. Combining various in vivo approaches, we show that the cannabinoid CB 1 receptor (CB 1 R), a key suppressor of synaptic transmission, is overactivated in CRBN deficiency-linked ARNSID mouse models, and that the memory deficits observed in these animals can be rescued by acute CB 1 R-selective pharmacological antagonism. Molecular studies demonstrated that CRBN interacts physically with CB 1 R and impairs the CB 1 R-G i/o -cAMP-PKA pathway in a ubiquitin ligase- independent manner. Taken together, these findings unveil that CB 1 R overactivation is a driving mechanism of CRBN deficiency- linked ARNSID and anticipate that the antagonism of CB 1 R could constitute a new therapy for this orphan disease., This work was supported by the Spanish Ministerio de Ciencia e Innovación (MICINN/FEDER; grants PID2021-125118OB-I00 to MG, PID2020-113938RB- I00 to EM and VC, PID2019-106579RB-I00 and PID2022-142617NB-I00 to GP, and PID2019-106404RB-I00 to LU), as well as by the Generalitat de Catalunya (grant 2021-SGR-00230 to EM and VC). LB was supported by INSERM. CC-I and IBM were supported by contracts from the Spanish Ministerio de Universidades (Formación de Profesorado Universitario Program, references FPU16/02593 and FPU15/01833, respectively). CC-I was also supported by an EMBO short-term fellowship (reference STF-8930). We are indebted to Dr. Benjamin L. Ebert for the kind donation of HEK-293T-CRBN-KO and parental HEK-293T-CRBN-WT cells. We also thank David Martín-Gutiérrez, Lucía Rivera-Endrinal, Dr. Daniel García-Ovejero, Dr. Eduardo Molina-Holgado, and the personnel of the core microscopy centre, the genomics unit, and the animal facilities of Universidad Complutense de Madrid for their expert technical assistance., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls

  • Costas-Insua, Carlos
  • Hermoso-López, Alba
  • Moreno, Estefanía
  • Diez-Alarcia, Rebeca
  • Álvaro-Blázquez, Alicia
  • Maroto, Irene B.
  • Sanchez-Ruiz, A.
  • Blázquez, Cristina
  • Morales, Paula
  • Canela, Enric I.
  • Casadó, Vicent
  • Urigüen, Leyre
  • Perea, Gertrudis
  • Bellocchio, Luigi
  • Rodríguez-Crespo, Ignacio
  • Guzmán, Manuel
Cereblon/CRBN is a substrate-recognition component of the Cullin4A-DDB1-Roc1 E3 ubiquitin ligase complex. Destabilizing mutations in the human CRBN gene cause a form of autosomal recessive non-syndromic intellectual disability (ARNSID) that is modelled by knocking-out the mouse Crbn gene. A reduction in excitatory neurotransmission has been proposed as an underlying mechanism of the disease. However, the precise factors eliciting this impairment remain mostly unknown. Here we report that CRBN molecules selectively located on glutamatergic neurons are necessary for proper memory function. Combining various in vivo approaches, we show that the cannabinoid CB1 receptor (CB1R), a key suppressor of synaptic transmission, is overactivated in CRBN deficiency-linked ARNSID mouse models, and that the memory deficits observed in these animals can be rescued by acute CB1R-selective pharmacological antagonism. Molecular studies demonstrated that CRBN interacts physically with CB1R and impairs the CB1R-Gi/o-cAMP-PKA pathway in a ubiquitin ligase-independent manner. Taken together, these findings unveil that CB1R overactivation is a driving mechanism of CRBN deficiency-linked ARNSID and anticipate that the antagonism of CB1R could constitute a new therapy for this orphan disease., This work was supported by the Spanish Ministerio de Ciencia e Innovación (MICINN/FEDER; grants PID2021-125118OB-I00 to MG, PID2020-113938RB-I00 to EM and VC, PID2019-106579RB-I00 and PID2022-142617NB-I00 to GP, and PID2019-106404RB-I00 to LU), as well as by the Generalitat de Catalunya (grant 2021-SGR-00230 to EM and VC). LB was supported by INSERM. CC-Iand IBM were supported by contracts from the Spanish Ministerio de Universidades (Formación de Profesorado Universitario Program, referencesFPU16/02593 and FPU15/01833, respectively). CC-I was also supported by an EMBO short-term fellowship (reference STF-8930). We are indebted to Dr.Benjamin L. Ebert for the kind donation of HEK-293T-CRBN-KO and parental HEK-293T-CRBN-WT cells. We also thank David Martín-Gutiérrez, Lucía Rivera-Endrinal, Dr. Daniel García-Ovejero, Dr. Eduardo Molina-Holgado, and the personnel of the core microscopy centre, the genomics unit, and the animal facilities of Universidad Complutense de Madrid for their expert technical assistance.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls

  • Costas-Insua, Carlos
  • Hermoso-López, Alba
  • Moreno, Estefanía
  • Montero-Fernández, Carlos
  • Álvaro-Blázquez, Alicia
  • Maroto, Irene B.
  • Sánchez-Ruiz, Andrea
  • Diez-Alarcia, Rebeca
  • Blázquez, Cristina
  • Morales, Paula
  • Canela, Enric I.
  • Casadó, Vicent
  • Urigüen, Leyre
  • Perea, Gertrudis
  • Bellocchio, Luigi
  • Rodríguez-Crespo, Ignacio
  • Guzmán, Manuel
Cereblon/CRBN is a substrate-recognition component of the Cullin4A-DDB1-Roc1 E3 ubiquitin ligase complex. Destabilizing mutations in the human CRBN gene cause a form of autosomal recessive non-syndromic intellectual disability (ARNSID) that is modelled by knocking-out the mouse Crbn gene. A reduction in excitatory neurotransmission has been proposed as an underlying mechanism of the disease. However, the precise factors eliciting this impairment remain mostly unknown. Here we report that CRBN molecules selectively located on glutamatergic neurons are necessary for proper memory function. Combining various in vivo approaches, we show that the cannabinoid CB1 receptor (CB1R), a key suppressor of synaptic transmission, is overactivated in CRBN deficiency-linked ARNSID mouse models, and that the memory deficits observed in these animals can be rescued by acute CB1R-selective pharmacological antagonism. Molecular studies demonstrated that CRBN interacts physically with CB1R and impairs the CB1R-Gi/o-cAMP-PKA pathway in a ubiquitin ligase-independent manner. Taken together, these findings unveil that CB1R overactivation is a driving mechanism of CRBN deficiency-linked ARNSID and anticipate that the antagonism of CB1R could constitute a new therapy for this orphan disease., This work was supported by the Spanish Ministerio de Ciencia e Innovación (MICINN/FEDER; grants PID2021-125118OB-I00 to MG, PID2020-113938RB-I00 to EM and VC, PID2019-106579RB-I00 and PID2022-142617NB-I00 to GP, and PID2019-106404RB-I00 to LU), as well as by the Generalitat de Catalunya (grant 2021-SGR-00230 to EM and VC). LB was supported by INSERM. CC-I and IBM were supported by contracts from the Spanish Ministerio de Universidades (Formación de Profesorado Universitario Program, references FPU16/02593 and FPU15/01833, respectively). CC-I was also supported by an EMBO short-term fellowship (reference STF-8930). We are indebted to Dr. Benjamin L. Ebert for the kind donation of HEK-293T-CRBN-KO and parental HEK-293T-CRBN-WT cells. We also thank David Martín-Gutiérrez, Lucía Rivera-Endrinal, Dr. Daniel García-Ovejero, Dr. Eduardo Molina-Holgado, and the personnel of the core microscopy centre, the genomics unit, and the animal facilities of Universidad Complutense de Madrid for their expert technical assistance., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Astrocytopathy Is Associated with CA1 Synaptic Dysfunction in a Mouse Model of Down Syndrome

  • Fernández-Blanco, Álvaro
  • González-Arias, Candela
  • Sierra, César
  • Zamora-Moratalla, Alfonsa
  • Perea, Gertrudis
  • Dierssen, Mara
This article belongs to the Special Issue Cellular and Molecular Alterations in the Down Syndrome Brain: A Starting Point for the Design of Therapeutic Approaches., Brain pathophysiology in Down syndrome (DS), the most common genetic cause of intellectual disability, has traditionally been considered a consequence of neuronal dysfunction. However, although it is well documented that astrocytes play a critical role in brain homeostasis, synaptic regulation, and neuronal support, and their malfunction has been associated with the onset and progression of different neurological disorders, only a few studies have addressed whether astrocyte dysfunction can contribute to the DS pathophysiology. Astrocytes are increased in number and size, and show increased levels of expression of astroglial markers like S100β and GFAP. In this study, we detected a region-specific increase in astrocyte population in CA1 and, to a lesser extent, in the dentate gyrus. Single-nucleus transcriptomic profiling identified markers associated with reactive astroglia, synaptic transmission, and neuroinflammation in trisomic astrocytes. Functional analysis revealed abnormal Ca2+ oscillations in trisomic astrocytes and impaired astrocyte-to-neuron communication in CA1, the most affected subregion, leading to astrocyte-mediated excitatory synaptic depression. Our findings demonstrate that astrocytes play an active and critical role in the pathophysiology of DS, not only as reactive responders to neuronal injury but as key contributors to the disease process itself. This astrocytic dysfunction presents a region-specific distribution within the hippocampus, suggesting localized vulnerability and complex glial involvement in DS-related neuropathology., The lab of MD is supported by the Secretaria d’Universitats i Recerca del Departament d’Economia I Coneixement de la Generalitat de Catalunya (Grups consolidats 2017 SGR 926). We also acknowledge the support of the Agencia Estatal de Investigación (PID2022-141900OB-I00 INTO-DS funded by MICIU/AEI/10.13039/501100011033/FEDER, UE). This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 848077). The publication is part of the grant PRE2018-084504, funded by MCIN/AEI/10.13039/501100011033 and by the FSE+ (AFB). Additionally, we have been supported by Fundació La Marató TV3 (201620-31 and 225619), and by PID2022-142617NB-I00 and PID2019-106579RB-I00 funded by MCIN/AEI/10.13039/501100011033 to G.P., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Restoration of CB1 receptor function in hippocampal GABAergic neurons rescues memory deficits in Huntington's disease models

  • Di Franco, Nadia
  • Bengoetxea de Tena, Iker
  • Sanchez-Ruiz, Andrea
  • Pereda-Velarde, Alba
  • Enfedaque, Ferran
  • Gónzalez-Arias, Candela
  • Rio, Lluis Maria Miquel
  • Bortolozzi, Analía
  • Rodriguez-Puertas, Rafael
  • Costas-Insua, Carlos
  • Molina-Porcel, Laura
  • Vazquez-Oliver, Anna
  • Ozaita, Andres
  • Guzmán, Manuel
  • Perea, Gertrudis
  • Ginés, Silvia
Dysregulation of the endocannabinoid system (eCBS) and the loss of CB1 receptors (CB1R) in the basal ganglia are well-established hallmarks of Huntington's disease (HD). As a result, significant research efforts have focused on targeting the eCBS to alleviate motor disturbances associated with the disease. Beyond its role in motor control, the eCBS is a complex signaling network critically involved in regulating learning and memory. Despite this, the potential involvement of eCBS dysfunction in the cognitive decline characteristic of HD, often manifested well before motor dysfunction, has remained largely unexplored., This work was supported by the Spanish Ministerio de Ciencia e Innovación (PID2021-123732OB-I00 to SG, PID2021-125118OB-I00 to MG, PID2019-106579RB-I00, and PID2022-142617NB-I00 to GP, and PID2022-141700OB-I00 to AB funded by MCIN/AEI/ https://doi.org/10.13039/501100011033). Fundació la Marató de TV3 (202013-30-31–32 to SG, MG and GP), AGAUR Generalitat de Catalunya (2021-SGR-01358 to AB and 2021-SGR 01086 to SG) and grants to R. R.-P. from the Basque Government IT1454-22 to the “Neurochemistry and Neurodegeneration” consolidated research group; Instituto de Salud Carlos III through the project PI20/00153 (co-funded by European Regional Development Fund “A way to make Europe”) and by BIOEF through the project BIO22/ALZ/010 funded by Eitb Maratoia. A P-V is the recipient of a PRE2022-101764 fellowship (PID2021-123732OB-I00). I.B.d.T. is the recipient of an Investigo fellowship funded by the European Union-Next Generation EU., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

When the Stars Misfire: Astrocytic Dysfunctions in Major Depressive Disorder

  • González-Arias, Candela
  • Perea, Gertrudis
Major depressive disorder (MDD) is a global public health concern and the leading cause of disability worldwide. It severely impairs cognitive, emotional, and social functioning, and is associated with attention, memory, and executive function deficits. MDD was traditionally considered as a neuropsychiatric disorder focused on neuronal dysfunction; however, growing evidence recognizes glial cells, particularly astrocytes, as crucial cells for the pathophysiology and pathogenesis of MDD. Astrocytes play essential roles in the central nervous system, including neurotransmitter uptake, metabolic support, neurotrophic factor production, and synaptic regulation. Evidence from MDD human patients, as well as studies involving animal models have revealed the astrocytic dysfunction as a critical factor in the pathophysiology of MDD, pointing to widespread alterations in astrocyte density, morphology, and function. This review summarizes current knowledge regarding astrocytes and MDD and discuss the potential of targeting astrocytes as a novel avenue for antidepressant development., We are grateful for critical reading to A. SánchezRuiz and A. Prosilis from Perea lab. This work was supported by the Spanish Ministerio de Ciencia e Innovación y Universidades (MICIU) #PID2022-142617NB-I00 and #PLEC2022-009385 MICIU/AEI/10.13039/501100011033 and by “ERDF A way of making Europe” to G.P.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

When the Stars Misfire: Astrocytic Dysfunctions in Major Depressive Disorder

  • González-Arias, Candela
  • Perea, Gertrudis
Major depressive disorder (MDD) is a global public health concern and the leading cause of disability worldwide. It severely impairs cognitive, emotional, and social functioning, and is associated with attention, memory, and executive function deficits. MDD was traditionally considered as a neuropsychiatric disorder focused on neuronal dysfunction; however, growing evidence recognizes glial cells, particularly astrocytes, as crucial cells for the pathophysiology and pathogenesis of MDD. Astrocytes play essential roles in the central nervous system, including neurotransmitter uptake, metabolic support, neurotrophic factor production, and synaptic regulation. Evidence from MDD human patients, as well as studies involving animal models have revealed the astrocytic dysfunction as a critical factor in the pathophysiology of MDD, pointing to widespread alterations in astrocyte density, morphology, and function. This review summarizes current knowledge regarding astrocytes and MDD and discuss the potential of targeting astrocytes as a novel avenue for antidepressant development., We are grateful for critical reading to A. SánchezRuiz and A. Prosilis from Perea lab. This work was supported by the Spanish Ministerio de Ciencia e Innovación y Universidades (MICIU) #PID2022-142617NB-I00 and #PLEC2022-009385 MICIU/AEI/ 10.13039/501100011033 and by “ERDF A way of making Europe” to G.P., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Tesis doctoral (DoctoralThesis)

The role of astrocytic metabotropic glutamate receptor 5 in cortico-limbic function and behavior, O envolvimento dos recetores metabotrópicos 5 de glutamato de astrócitos na função cognitiva

  • Perea, Gertrudis
  • Oliveira Viana, Joao Filipe
Over the years, increasing evidence has been demonstrating the key role of astrocytes in the brain, namely in modulations of synapses, neuronal networks and behavior, proving that these are more than mere supportive cells. Indeed, astrocytes gained recognition as the third active element of a synapse. In this tripartite synapse concept, while interacting closely with neurons, these cells can modulate neuronal activity by sensing, processing, integrating and responding to synaptic transmission. Astrocytes were firstly shown to sense glutamate, the most abundant excitatory neurotransmitter in the brain, which occurs mostly by activation of metabotropic glutamate receptor 5 (mGluR5). Activation of mGluR5 triggers Ca2+ elevations in astrocytes with consequences for synaptic function in cortico-limbic areas that are critical for cognitive processing. However, the majority of these studies were focused on the biological role of mGluR5 in young rodents, often using in vitro or ex vivo approaches. Thus, further studies are needed to better understand the impact of astrocytic mGluR5 in cognitive processing of adult mice. In this dissertation, we have generated two mouse models with temporally controlled deletion of mGluR5 in astrocytes, taking advantage of a mouse line carrying the mGluR5 flanked by loxP sites. Firstly, by inducing genetic recombination through a tamoxifen-inducible Cre--loxP system in astrocytes from the whole brain (GLAST-mGluR5KO mouse) and secondly by inducing ablation of the gene specifically in astrocytes from the hippocampus, following an injection of a rAAV5-GFAP-mCherry-Cre virus (dHIP-GFAPmGluR5KO mouse). A detailed behavior characterization of these mouse models showed that GLASTmGluR5KO and dHIP-GFAP-mGluR5KO mice do not present any anxious- or depressive -like phenotype or abnormal locomotor activity. Furthermore, cognitive assessment of these mice showed that GLASTmGluR5KO mice display normal spatial reference memory but enhanced behavior flexibility in Morris Water Maze (MWM). However, in the Contextual Fear Conditioning (CFC) these mice presented impaired fear memory. The behavioral assessment of dHIP-GFAP-mGluR5KO mice also revealed normal spatial reference memory, but impaired behavior flexibility, as shown in the reversal learning task of the MWM. In addition to behavior characterization, molecular analysis of GLAST-mGluR5KO mice showed a decreased expression levels of GFAP gene upon mGluR5 deletion. Overall, by using these different approaches to modulate astrocytic mGluR5 in adulthood we observed region-specific cognitive phenotypes. These evidences confirm the involvement of astrocytic mGluR5 in cognition and opens future perspectives in the field that urge to be addressed., Ao longo dos anos, vários estudos têm vindo a demonstrar que os astrócitos desempenham funções fundamentais no cérebro, nomeadamente na modulação de sinapses, redes neuronais e comportamento. De facto, os astrócitos têm vindo a ganhar reconhecimento como o terceiro elemento ativo nas sinapses, formando sinapses tripartidas. Neste conceito, estas células interagem diretamente com os neurónios modulando a sua atividade através da deteção e integração de transmissão sináptica. Os astrócitos são ativados por glutamato, o neurotransmissor excitatório mais abundante no cérebro e o primeiro a ser relacionado com ativação de astrócitos, através do recetor metabotrópico 5 de glutamato (mGluR5). Uma vez ativado, este recetor induz elevações intracelulares de Ca2+ em astrócitos com consequências para a atividade sináptica nas regiões cortico-límbicas, importantes para a função cognitiva. No entanto, a maioria dos estudos utilizou roedores jovens geralmente usando abordagens in vitro e ex vivo, sendo necessária a confirmação destas observações em murganhos adultos. Nesta dissertação, nós geramos dois modelos de murganho adulto com a deleção mGluR5 em astrócitos, usando uma linha de murganhos que possui o gene mGluR5 flanqueado por sequências loxP. Primeiro, usando um sistema Cre-lox dependente de tamoxifeno para deleção condicional em astrócitos em todo o cérebro (GLAST-mGluR5KO). Em segundo lugar, através da injeção do vírus rAAV5:GFAP-mCherry-Cre para deletar o gene apenas em astrócitos do hipocampo (dHIP-GFAP-mGluR5KO). Uma caracterização detalhada do seu comportamento mostrou que nenhum dos modelos apresenta fenótipos do tipo ansioso ou depressivo, ou mesmo atividade motora anormal. Além disso, a avaliação da função cognitiva mostrou que os murganhos GLAST-mGluR5KO apresentam memória de referência espacial normal, mas maior flexibilidade comportamental no Morris Water Maze (MWM) e défices na memória associada a medo no Contextual Fear Conditioning (CFC). No entanto, os dHIP-GFAP-mGluR5KO possuem memória associada ao medo e memória de referências espaciais normal, mas menor flexibilidade comportamental. Uma posterior análise molecular dos cérebros dos GLAST-mGluR5KO revelou níveis de expressão do gene GFAP diminuídos. Em suma, ao usar duas abordagens para modular a expressão do mGluR5 em astrócitos na idade adulta, observamos fenótipos cognitivos dependentes de áreas especificas do cérebro. Estas descobertas contribuíram para identificar o envolvimento do mGluR5 na cognição, abrindo também portas para novos estudos nesta área., The work presented in this thesis was performed in the Life and Health Sciences Research Institute (ICVS), University of Minho. The authors acknowledge the Foundation for Science and Technology (FCT) fellowships to JF Viana 2020.05109.BD; grant from ”la Caixa” Foundation (LCF/PR/HR21/52410024) to JFO; National funds project UIDB/50026/2020 (DOI 10.54499/UIDB/50026/2020), UIDP/50026/2020 (DOI 10.54499/UIDP/50026/2020) and LA/P/0050/2020 (DOI 10.54499/LA/P/0050/2020). Part of the work was performed at the Neuron-Glia Netwoks lab, Cajal Institute by funds from Ministerio de Ciencia e Innovación. Universidades, Spain, PID2022-142617NBI00 trough funds to GP.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Restoration of CB1 receptor function in hippocampal GABAergic neurons rescues memory deficits in Huntington's disease models

  • Franco, Nadia Di
  • Bengoetxea de Tena, Iker
  • Sanchez-Ruiz, Andrea
  • Pereda-Velarde, Alba
  • Enfedaque, Ferran
  • González-Arias, Candela
  • Miquel-Rio, Lluis
  • Bortolozzi, Analía
  • Rodríguez-Puertas, Rafael
  • Costas-Insua, Carlos
  • Molina-Porcel, Laura
  • Vázquez-Oliver, Anna
  • Ozaita Mintegui, Andrés, 1969-
  • Guzmán, Manuel
  • Perea, Gertrudis
  • Ginés, Silvia
Background: Dysregulation of the endocannabinoid system (eCBS) and the loss of CB1 receptors (CB1R) in the basal ganglia are well-established hallmarks of Huntington's disease (HD). As a result, significant research efforts have focused on targeting the eCBS to alleviate motor disturbances associated with the disease. Beyond its role in motor control, the eCBS is a complex signaling network critically involved in regulating learning and memory. Despite this, the potential involvement of eCBS dysfunction in the cognitive decline characteristic of HD, often manifested well before motor dysfunction, has remained largely unexplored. Methods: CB1R expression in the hippocampus was evaluated in both human HD samples and HD mouse models (R6/1 and Hdh models, including both sexes) using Western blotting, immunohistochemistry, and radioligand binding assays. To restore CB1R function, CB1R agonist WIN-55212-2 was systemically administered, or viral vectors encoding CB1R were locally infused into the hippocampus of HD mice. A multidisciplinary approach combining behavioral, biochemical, electrophysiological, and morphological analyses, was employed to investigate the molecular mechanisms underlying the effects of CB1R activation in the context of HD-related cognitive dysfunction. Results: In both human HD samples and HD mouse models, CB1R protein levels were reduced in the hippocampus, accompanied by structural synaptic alterations and impairment in spatial, recognition and working memory. Moreover, hippocampal depolarization-induced suppression of inhibition was significantly disrupted in R6/1 mice. Administration of WIN-55212-2 successfully restored these synaptic and cognitive deficits. Immunohistochemical analysis revealed that the CB1R decrease was specifically localized to GABAergic interneurons within the hippocampus. Notably, targeted restoration of CB1R expression in these interneurons via viral vector delivery was sufficient to rescue hippocampal-dependent memory deficits in HD mice. Conclusion: This study suggests that impaired CB1R function in hippocampal GABAergic interneurons contributes to memory dysfunction in HD., This work was supported by the Spanish Ministerio de Ciencia e Innovación (PID2021-123732OB-I00 to SG, PID2021-125118OB-I00 to MG, PID2019-106579RB-I00, and PID2022-142617NB-I00 to GP, and PID2022-141700OB-I00 to AB funded by MCIN/AEI/ https://doi.org/10.13039/501100011033). Fundació la Marató de TV3 (202013-30-31-32 to SG, MG and GP), AGAUR Generalitat de Catalunya (2021-SGR-01358 to AB and 2021-SGR 01086 to SG) and grants to R. R.-P. rom the Basque Government IT1454-22 to the "Neurochemistry and Neurodegeneration" consolidated research group; Instituto de Salud Carlos III through the project PI20/00153 (co-funded by European Regional Development Fund "A way to make Europe") and by BIOEF through the project BIO22/ALZ/010 funded by Eitb Maratoia. A P-V is the recipient of a PRE2022-101764 fellowship (PID2021-123732OB-I00). I.B.d.T. is the recipient of an Investigo fellowship funded by the European Union-Next Generation EU.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Astrocytopathy is associated with CA1 synaptic dysfunction in a mouse model of Down syndrome

  • Fernández-Blanco, Álvaro
  • González-Arias, Candela
  • Sierra, Cesar
  • Zamora Moratalla, Alfonsa
  • Perea, Gertrudis
  • Dierssen, Mara
Brain pathophysiology in Down syndrome (DS), the most common genetic cause of intellectual disability, has traditionally been considered a consequence of neuronal dysfunction. However, although it is well documented that astrocytes play a critical role in brain homeostasis, synaptic regulation, and neuronal support, and their malfunction has been associated with the onset and progression of different neurological disorders, only a few studies have addressed whether astrocyte dysfunction can contribute to the DS pathophysiology. Astrocytes are increased in number and size, and show increased levels of expression of astroglial markers like S100ß and GFAP. In this study, we detected a region-specific increase in astrocyte population in CA1 and, to a lesser extent, in the dentate gyrus. Single-nucleus transcriptomic profiling identified markers associated with reactive astroglia, synaptic transmission, and neuroinflammation in trisomic astrocytes. Functional analysis revealed abnormal Ca2+ oscillations in trisomic astrocytes and impaired astrocyte-to-neuron communication in CA1, the most affected subregion, leading to astrocyte-mediated excitatory synaptic depression. Our findings demonstrate that astrocytes play an active and critical role in the pathophysiology of DS, not only as reactive responders to neuronal injury but as key contributors to the disease process itself. This astrocytic dysfunction presents a region-specific distribution within the hippocampus, suggesting localized vulnerability and complex glial involvement in DS-related neuropathology., The lab of MD is supported by the Secretaria d¿Universitats i Recerca del Departament d'Economia I Coneixement de la Generalitat de Catalunya (Grups consolidats 2017 SGR 926). We also acknowledge the support of the Agencia Estatal de Investigación (PID2022-141900OB-I00 INTO-DS funded by MICIU/AEI/10.13039/501100011033/FEDER, UE). This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 848077). The publication is part of the grant PRE2018-084504, funded by MCIN/AEI/10.13039/501100011033 and by the FSE+ (AFB). Additionally, we have been supported by Fundació La Marató TV3 (201620-31 and 225619), and by PID2022-142617NB-I00 and PID2019-106579RB-I00 funded by MCIN/AEI/10.13039/501100011033 to G.P.